Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication March 27, 2015
- Accepted for publication March 27, 2015
- Published online June 1, 2015.
Article Versions
- previous version (April 16, 2015 - 06:57).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Author Information
- Michael M. Graham1,
- Richard L. Wahl2,
- John M. Hoffman3,
- Jeffrey T. Yap3,
- John J. Sunderland1,
- Ronald Boellaard4,
- Eric S. Perlman5,
- Paul E. Kinahan6,
- Paul E. Christian3,
- Otto S. Hoekstra4 and
- Gary S. Dorfman7
- 1Division of Nuclear Medicine, Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa
- 2Department of Radiology, Washington University School of Medicine, St. Louis, Missouri
- 3Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah
- 4Department of Radiology and Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands
- 5Perlman Advisory Group, LLC, Hillsdale, New York
- 6Department of Radiology, University of Washington, Seattle, Washington; and
- 7Department of Radiology, Weill Cornell Medical College, New York, New York
- For correspondence or reprints contact: Michael M. Graham, Division of Nuclear Medicine, Department of Radiology, Room 3863 JPP, University of Iowa Hospitals and Clinics, 200 Hawkins Dr., Iowa City, IA 52242. E-mail: michael-graham{at}uiowa.edu
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
- Article
- Abstract
- CONTEXT OF THE IMAGING PROTOCOL WITHIN THE CLINICAL TRIAL
- SITE SELECTION, QUALIFICATION, AND TRAINING
- SUBJECT SCHEDULING
- SUBJECT PREPARATION
- IMAGING-RELATED SUBSTANCE PREPARATION AND ADMINISTRATION
- IMAGING PROCEDURE
- IMAGE POSTPROCESSING
- IMAGE ANALYSIS
- IMAGE INTERPRETATION
- ARCHIVING AND DISTRIBUTION OF DATA
- Quality Control (QC)
- IMAGING-ASSOCIATED RISKS AND RISK MANAGEMENT
- DISCLOSURE
- Acknowledgments
- Footnotes
- REFERENCES
- Figures & Data
- Supplemental
- Info & Metrics
Related Articles
Cited By...
- Advantages and Challenges of Total-Body PET/CT at a Tertiary Cancer Center: Insights from Sun Yat-sen University Cancer Center
- Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
- Brown Adipose Tissue: A Protective Mechanism Against "Preprediabetes"?
- Combining 18F-FDG PET/CT-Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer
- Test-Retest Reproducibility of 18F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network
- Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point 18F-FDG PET/CT Imaging in Patients with Advanced Melanoma
- Qualification of National Cancer Institute-Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials
- Does PET SUV Harmonization Affect PERCIST Response Classification?
- Translation of New Molecular Imaging Approaches to the Clinical Setting: Bridging the Gap to Implementation
- Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size
- Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy
- The Value of Establishing the Quantitative Accuracy of PET/CT Imaging